The US Food and Drug Administration (FDA) and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ microphysiological systems (MPS) using the PhysioMimix Multi-organ System. The system will initially be investigated for improving the preclinical estimation of human drug bioavailability compared to standard animal models. Dr Emily […]
